Ana Boban

512 total citations
33 papers, 302 citations indexed

About

Ana Boban is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, Ana Boban has authored 33 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 5 papers in Internal Medicine and 4 papers in Genetics. Recurrent topics in Ana Boban's work include Hemophilia Treatment and Research (17 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Ana Boban is often cited by papers focused on Hemophilia Treatment and Research (17 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Ana Boban collaborates with scholars based in Croatia, United States and Belgium. Ana Boban's co-authors include Cédric Hermans, Catherine Lambert, Dubravka Sertić, Boris Labar, Damir Nemet, Nadira Duraković, Mirando Mršić, Stefan Lethagen, Vedran Radojčić and C. R. M. Hay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Ana Boban

28 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Boban Croatia 10 209 77 50 35 27 33 302
A. M. Testi Italy 9 249 1.2× 43 0.6× 87 1.7× 11 0.3× 12 0.4× 21 352
Anke Verlinden Belgium 9 54 0.3× 10 0.1× 17 0.3× 17 0.5× 21 0.8× 20 212
Dharma Choudhary India 8 149 0.7× 67 0.9× 17 0.3× 4 0.1× 8 0.3× 45 229
Luciana Tucunduva Brazil 11 181 0.9× 43 0.6× 33 0.7× 3 0.1× 5 0.2× 27 282
Savaş Kansoy Türkiye 10 55 0.3× 56 0.7× 20 0.4× 4 0.1× 13 0.5× 18 219
Luisa Verga Italy 10 77 0.4× 32 0.4× 15 0.3× 10 0.3× 9 0.3× 33 288
Zeyad Al‐Shaibani Canada 10 194 0.9× 33 0.4× 12 0.2× 9 0.3× 4 0.1× 38 260
Damianos Sotiropoulos Greece 8 92 0.4× 27 0.4× 20 0.4× 9 0.3× 3 0.1× 28 172
Jimmy P.S. Chern Taiwan 10 214 1.0× 306 4.0× 67 1.3× 7 0.2× 1 0.0× 12 379
S. H. Lim United Kingdom 5 30 0.1× 15 0.2× 9 0.2× 7 0.2× 18 0.7× 9 133

Countries citing papers authored by Ana Boban

Since Specialization
Citations

This map shows the geographic impact of Ana Boban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Boban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Boban more than expected).

Fields of papers citing papers by Ana Boban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Boban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Boban. The network helps show where Ana Boban may publish in the future.

Co-authorship network of co-authors of Ana Boban

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Boban. A scholar is included among the top collaborators of Ana Boban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Boban. Ana Boban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sidonio, Robert F., et al.. (2025). Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate—Analyses from the WIL-31 study. Research and Practice in Thrombosis and Haemostasis. 10(1). 103327–103327.
2.
3.
Sidonio, Robert F., et al.. (2025). Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease—a WIL-31 subanalysis. Research and Practice in Thrombosis and Haemostasis. 9(7). 103221–103221. 1 indexed citations
4.
Babel, Jakša, et al.. (2025). Refractory delayed-onset heparin induced thrombocytopenia (HIT) without thrombosis, treated with intravenous immunoglobulin. Transfusion and Apheresis Science. 64(3). 104118–104118.
5.
Sidonio, Robert F., Ana Boban, Adlette Inati, et al.. (2024). von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease. Blood Advances. 8(6). 1405–1414. 10 indexed citations
6.
Rezende, Suely Meireles, Ignacio Neumann, Pantep Angchaisuksiri, et al.. (2024). International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology. Journal of Thrombosis and Haemostasis. 22(9). 2629–2652. 13 indexed citations
7.
Zápotocká, Ester, Angelika Bátorová, Ernest Bilić, et al.. (2024). florio® HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe. Advances in Therapy. 41(7). 2791–2807. 1 indexed citations
8.
9.
Bodó, Imre, Ana Boban, Horia Bumbea, et al.. (2023). Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations. Advances in Therapy. 40(6). 2752–2772. 9 indexed citations
10.
Boban, Ana, Fariba Baghaei, Robert Klamroth, et al.. (2023). Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy. Haemophilia. 29(6). 1442–1449. 7 indexed citations
11.
Zápotocká, Ester, Angelika Bátorová, Ernest Bilić, et al.. (2022). First experience of a hemophilia monitoring platform: florio HAEMO. Research and Practice in Thrombosis and Haemostasis. 6(2). e12685–e12685. 3 indexed citations
12.
Windyga, Jerzy, Ana Boban, Irena Zupan, Niamh O’Connell, & Cédric Hermans. (2022). Changing paradigms of hemophilia care across larger specialized treatment centers in the European region. Therapeutic Advances in Hematology. 13. 1554006222–1554006222. 2 indexed citations
13.
Bátorová, Angelika, et al.. (2022). Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A. Journal of Medicine and Life. 15(4). 570–578. 10 indexed citations
14.
Raso, Simona, Catherine Lambert, Ana Boban, et al.. (2019). Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?. Haemophilia. 26(1). 117–121. 19 indexed citations
15.
Iorio, Alfonso, Andrea N. Edginton, Victor S. Blanchette, et al.. (2018). Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations. Research and Practice in Thrombosis and Haemostasis. 2(3). 535–548. 45 indexed citations
16.
Boban, Ana, et al.. (2016). The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin during pregnancy. Blood Coagulation & Fibrinolysis. 28(3). 199–204. 17 indexed citations
17.
Berntorp, Erik, Gerard Dolan, C. R. M. Hay, et al.. (2016). European retrospective study of real‐life haemophilia treatment. Haemophilia. 23(1). 105–114. 56 indexed citations
18.
Boban, Ana, Catherine Lambert, & Cédric Hermans. (2016). Is the cardiovascular toxicity of NSAIDS and COX-2 selective inhibitors underestimated in patients with haemophilia?. Critical Reviews in Oncology/Hematology. 100. 25–31. 5 indexed citations
19.
Boban, Ana, et al.. (2009). Acute promyelocytic leukemia after whole brain irradiation of primary brain lymphomainan HIV-infected patient. European journal of medical research. 14(1). 42–3. 4 indexed citations
20.
Zemunik, Tatijana, et al.. (2002). Growth and motor activity in the progeny of adolscent rats. Croatian Medical Journal. 37(3). 210–213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Testi Breakdown of academic impact, for papers by Anke Verlinden Breakdown of academic impact, for papers by Dharma Choudhary Breakdown of academic impact, for papers by Luciana Tucunduva Breakdown of academic impact, for papers by Savaş Kansoy Breakdown of academic impact, for papers by Luisa Verga Breakdown of academic impact, for papers by Zeyad Al‐Shaibani Breakdown of academic impact, for papers by Damianos Sotiropoulos Breakdown of academic impact, for papers by Jimmy P.S. Chern Breakdown of academic impact, for papers by S. H. Lim
Rankless by CCL
2026